Healthcare Sector

Members of Parliament invested in the Healthcare Sector

151 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£128.23	196.55%	£207,587.87
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£128.23	177.98%	£194,582.69
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£11,324.00	-5.82%	£65,924.82
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£11,324.00	175.12%	£192,585.03
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£11,324.00	192.12%	£204,483.43
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£11,324.00	52.57%	£106,801.40
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£11,324.00	-3.82%	£67,324.61
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£11,324.00	324.68%	£297,273.58
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£11,324.00	-6.84%	£65,208.95
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£11,324.00	109.05%	£146,331.92
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£11,324.00	-5.03%	£66,477.69
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£11,324.00	10.69%	£77,485.83
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£11,324.00	41.46%	£99,023.11
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£11,324.00	285.43%	£269,802.59
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£2.78	-16.01%	£58,791.54
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£37.15	-0.64%	£69,550.69
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£37.15	-30.47%	£48,671.16
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£37.15	-13.16%	£60,787.76
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£37.15	-5.66%	£66,036.06
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£37.15	-12.20%	£61,463.01
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£37.15	-5.93%	£65,852.11
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£37.15	-16.98%	£58,111.73
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£37.15	-15.61%	£59,075.42
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£37.15	-0.59%	£69,587.91
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£164.74	-0.18%	£69,876.99
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£164.74	34.33%	£94,029.68
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£164.74	126.63%	£158,643.56
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£164.74	170.38%	£189,263.10
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£164.74	1.87%	£71,307.20
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£197.16	116.80%	£151,762.08
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£197.16	173.25%	£191,273.54
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£197.16	-20.78%	£55,452.57
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£261.80	107.61%	£145,329.10
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£249.56	-1.45%	£68,988.23
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£249.56	-49.08%	£35,647.06
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£249.56	-53.60%	£32,480.89
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£249.56	-51.84%	£33,711.31
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£249.56	-58.01%	£29,389.64
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,233.68	83.45%	£128,414.71
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£467.68	11.85%	£78,293.39
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£467.68	1.84%	£71,286.47
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£467.68	-19.87%	£56,092.11
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£467.68	1.00%	£70,701.45
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£204.00	-66.70%	£23,310.48
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£204.00	-36.25%	£44,625.00
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£47.07	29.49%	£90,643.75
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£47.07	-53.71%	£32,401.42
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£47.07	-61.65%	£26,842.36
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£47.07	-65.05%	£24,468.29
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£145.79	-13.27%	£60,709.69
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£145.79	-10.46%	£62,678.41
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£113.74	28.69%	£90,085.99
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£113.74	72.21%	£120,544.96
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£113.74	110.47%	£147,328.28
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£218.00	-4.18%	£67,076.92
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£257.10	2.08%	£71,459.20
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£257.10	-16.97%	£58,120.46
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£257.10	0.51%	£70,355.75
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£257.10	-15.15%	£59,396.04
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£126.19	399.44%	£349,608.43
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£126.19	15.96%	£81,173.50
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£126.19	283.56%	£268,489.35
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.26	-84.92%	£10,555.34
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£23.29	19.16%	£83,414.38
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£23.29	-19.75%	£56,173.14
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£30.56	35.19%	£94,633.75
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£30.56	45.66%	£101,961.87
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£288.76	231.57%	£232,095.55
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£392.73	465.73%	£396,011.26
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£392.73	42.81%	£99,967.64
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£33.30	-30.33%	£48,765.69
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£33.30	-39.40%	£42,420.38
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£0.35	-97.25%	£1,923.50
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£62.10	-21.83%	£54,720.54
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£62.10	17.93%	£82,548.42
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£27.35	-71.29%	£20,097.63
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£129.01	-52.87%	£32,988.86
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£189.02	17.54%	£82,279.71
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£481.09	73.15%	£121,203.16
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£481.09	37.14%	£96,001.31
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£4.10	17.82%	£82,471.26
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.02	-99.91%	£66.04
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£353.99	1,041.17%	£798,816.87
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£31.00	23.95%	£86,764.60
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,495.00	-6.83%	£65,216.58
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£534.31	1,683.41%	£1,248,387.89
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£740.07	1.20%	£70,836.56
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,964.00	-3.06%	£67,857.85
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£3.90	-90.99%	£6,306.31
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£666.60	19.68%	£83,773.79
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£6.45	360.36%	£322,250.01
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.35	96.52%	£137,566.84
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.98	-44.18%	£39,074.33
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£1.85	-3.65%	£67,447.92
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.53	47.12%	£102,980.77
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£35.50	135.88%	£165,116.28
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.08	-94.56%	£3,809.52
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.46	-96.21%	£2,654.17
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£3.52	-66.85%	£23,201.51
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.75	-40.00%	£42,000.00
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£36.80	22.34%	£85,638.30
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£29.56	-73.60%	£18,478.30
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.64	-73.45%	£18,581.53
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£359.50	6.96%	£74,873.55
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£2.06	-83.72%	£11,399.21
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£260.60	25.59%	£87,913.26
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£260.60	-4.61%	£66,771.59
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.55	-97.88%	£1,480.77
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£51.50	-54.02%	£32,187.50
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£51.50	0.00%	£70,000.00
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£71.39	308.64%	£286,050.39
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£2.77	-90.77%	£6,463.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£1.88	-52.41%	£33,316.46

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.